http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113292465-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C319-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60 |
| filingDate | 2021-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113292465-B |
| titleOfInvention | A kind of cysteine derivative and its synthetic method and application |
| abstract | The present invention relates to the technical field of antitumor drugs, in particular to a cysteine derivative, a method for synthesizing the same, and its application as a histone deacetylase inhibitor in the preparation of antitumor drugs. The cysteine derivative has a potential inhibitory effect on HDAC, and can significantly inhibit HDAC both in vitro and in vivo, thereby producing anti-tumor activity; the synthetic raw material of the present invention is relatively cheap and low in cost, and is expected to become a novel HDAC inhibitor that can efficiently inhibit HDAC class of antitumor drugs. |
| priorityDate | 2021-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.